香港股市 已收市

Sumitomo Corporation (SSUMF)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
14.000.00 (0.00%)
收市價: 10:35AM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價14.00
開市14.00
買盤0.00 x 0
賣出價0.00 x 0
今日波幅14.00 - 14.00
52 週波幅13.12 - 18.17
成交量1
平均成交量1,576
市值17.956B
Beta 值 (5 年,每月)0.92
市盈率 (最近 12 個月)7.62
每股盈利 (最近 12 個月)1.84
業績公佈日
遠期股息及收益率0.69 (4.92%)
除息日2022年9月29日
1 年預測目標價
  • Benzinga

    Jazz Pharma, Sumitomo Pharma Ink Licensing Pact For Sleeping Disorder Candidate

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders. Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase 1 trial in Japan of DSP-0187 in November 2021 to evaluate the safe